AVD

Business Context and Reporting Period

This Form 8-K Current Report for American Vanguard Corporation covers events occurring between June 5, 2013, and June 10, 2013. The filing details the results of the 2013 Annual Meeting of Stockholders, the awarding of performance-based equity to executives, the extension of a strategic co-marketing agreement, and the initiation of a quarterly dividend policy and stock repurchase program.

Key Financial Metrics and Corporate Actions

The filing does not provide specific revenue, profit, cash flow, or debt figures for the reporting period. However, it discloses the following financial actions and metrics:

• Dividend Declaration: A quarterly cash dividend of $0.05 per share was declared. The record date is July 5, 2013, with payment on July 19, 2013.
• Stock Repurchase: The Board authorized a repurchase of common stock with the intent of maintaining the level of issued and outstanding shares.
• Executive Compensation: Performance-based equity awards were granted to named executive officers, contingent on net sales, net income, and total shareholder return (TSR) targets for fiscal years 2013 through 2015.

Material Changes and Strategic Developments

Significant corporate developments reported include:

• Strategic Partnership: Amvac Chemical Corporation, a wholly-owned subsidiary, extended its agreement with Monsanto Company to co-market the post-emergent corn herbicide Impact as part of the Roundup Ready PLUS weed management platform.
• Capital Allocation Policy: The company established a new policy of paying quarterly cash dividends, marking a shift in capital return strategy.
• Governance: The 2013 Annual Meeting resulted in the election of eight directors and the ratification of BDO USA, LLP as independent auditors.

Executive Equity Awards

On June 6, 2013, the Board awarded two types of performance-based shares to executives. Vesting requires continuous employment through the third anniversary and meeting specific financial or TSR targets.

Note: Sales/Income Shares vest based on net sales (3/8 weight) and net income (5/8 weight) targets from April 1, 2013, to December 31, 2015. TSR Shares vest based on annualized shareholder return targets of 8% to 12% for fiscal years 2014 and 2015.

Shareholder Vote Results

At the June 5, 2013 Annual Meeting, shareholders approved the following:

• Director Election: All eight nominees were elected. Broker non-votes totaled 3,166,352.
• Proposal 2 (Auditor Ratification): Approved with 24,857,489 votes for vs. 1,216,246 against.
• Proposal 3 (Say-on-Pay): Approved with 22,109,527 votes for vs. 758,131 against.
• Proposal 4 (Stock Plan Amendment): Approved with 22,565,714 votes for vs. 303,598 against.

Guidance, Risks, and Contingencies

The filing does not contain forward-looking financial guidance or specific risk factors beyond standard disclosures. Key contingencies noted include:

• Clawback Provisions: Executive equity awards are subject to adjustment or forfeiture in the event of a financial restatement or termination for cause.
• Performance Conditions: The value of the new equity awards is entirely contingent on meeting future sales, income, and stock price performance targets.

Investor Verification Checklist

• Verify the impact of the new quarterly dividend policy on future cash flow and liquidity.
• Review the terms of the extended co-marketing agreement with Monsanto to assess revenue stability for the Impact herbicide.
• Monitor the execution of the stock repurchase program to determine if it will offset dilution from the new equity awards.
• Track the company's progress against the specific net sales and net income targets required for executive vesting (April 2013–December 2015).
• Confirm the total number of shares outstanding following the repurchase authorization and dividend payment.